Arrowhead Pharmaceuticals, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2015 | $22.1M | $132.3M | $81.2M |
| FY2016 | $32.6M | $128.2M | $85.4M |
| FY2017 | $22.6M | $104.0M | $24.8M |
| FY2018 | $15.8M | $111.6M | $30.1M |
| FY2019 | $105.3M | $349.8M | $221.8M |
| FY2020 | $60.7M | $522.5M | $143.6M |
| FY2021 | $301.3M | $710.1M | $184.4M |
| FY2022 | $293.4M | $691.9M | $108.0M |
| FY2023 | $494.2M | $765.6M | $110.9M |
| FY2024 | $954.4M | $1.14B | $102.7M |